Suppr超能文献

与肾细胞癌相关的核基质蛋白改变的鉴定。

Identification of nuclear matrix protein alterations associated with renal cell carcinoma.

作者信息

Konety B R, Nangia A K, Nguyen T S, Veitmeier B N, Dhir R, Acierno J S, Becich M J, Hrebinko R L, Getzenberg R H

机构信息

Department of Pathology, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pennsylvania 15213, USA.

出版信息

J Urol. 1998 Apr;159(4):1359-63.

PMID:9507884
Abstract

PURPOSE

Neoplastic transformation, including renal cell carcinoma (RCC), is always accompanied by changes in nuclear morphology. Nuclear grading of RCC is based on characteristic alterations in nuclear shape, size, area and other morphologic parameters. The nuclear matrix, which forms the skeleton of the nucleus, determines nuclear morphology. Alterations in nuclear matrix protein (NMP) composition specific to tissue and cancer type have been described in a variety of human cancers. We conducted a study to analyze the nuclear matrix protein composition of renal cell carcinoma and compare it to that of normal renal tissue and renal cell carcinoma cells grown in culture.

MATERIALS AND METHODS

We analyzed the nuclear matrix protein composition of RCC tumor tissue and that of normal kidney tissue obtained from seventeen patients undergoing radical nephrectomy for RCC. We also analyzed the NMP composition of two renal cancer cell lines (A-498 and 769-P).

RESULTS

We were able to identify five different and unique NMPs which were present only in the human RCC tumor samples and were absent in all normal kidney tissue. One NMP was found specifically in the normal kidney tissue. All five RCC specific NMPs were also identified in the nuclear matrix of the two cell lines analyzed.

CONCLUSIONS

Five nuclear matrix proteins specific and unique to RCC were identified. These NMPs are different from those previously identified in other tissues and neoplasms. The RCC specific NMPs identified in this study can potentially be used as diagnostic markers for renal cell carcinoma and for therapeutic tumor targeting.

摘要

目的

肿瘤转化,包括肾细胞癌(RCC),总是伴随着核形态的变化。肾细胞癌的核分级基于核形状、大小、面积和其他形态学参数的特征性改变。构成细胞核骨架的核基质决定了核形态。在多种人类癌症中已描述了特定于组织和癌症类型的核基质蛋白(NMP)组成的改变。我们进行了一项研究,以分析肾细胞癌的核基质蛋白组成,并将其与正常肾组织和培养的肾癌细胞的核基质蛋白组成进行比较。

材料与方法

我们分析了17例因肾细胞癌接受根治性肾切除术患者的肾细胞癌肿瘤组织和正常肾组织的核基质蛋白组成。我们还分析了两种肾癌细胞系(A-498和769-P)的NMP组成。

结果

我们能够鉴定出五种不同且独特的NMP,它们仅存在于人类肾细胞癌肿瘤样本中,而在所有正常肾组织中均不存在。在正常肾组织中特异性发现了一种NMP。在分析的两种细胞系的核基质中也鉴定出了所有五种肾细胞癌特异性NMP。

结论

鉴定出了五种肾细胞癌特异性且独特的核基质蛋白。这些NMP与先前在其他组织和肿瘤中鉴定出的不同。本研究中鉴定出的肾细胞癌特异性NMP可能潜在地用作肾细胞癌的诊断标志物和治疗性肿瘤靶向。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验